Isiah Thomas Releases Letter to One World Pharma Shareholders

LAS VEGAS, NV, Jan. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to release a shareholder letter from its Chief Executive Officer, Isiah Thomas.

“After one of the most challenging years in human history, I can only hope that this letter finds you and yours safe and well.  We enter 2021 with an appreciation of our character and strength and a genuine belief in a better tomorrow,” stated Isiah Thomas, Chief Executive Officer, One World Pharma. “To that end, this letter provides me the best opportunity to review my thoughts on our accomplishments from the past year and my vision for One World Pharma’s future.”

The letter is available in full at the following link:

https://oneworldpharma.com/media/

About One World Pharma

Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.

One World Pharma Investor Relations & Financial Media

Kurt Divich, CEO

Integrity Media Inc.

[email protected]

Toll Free: (888) 216-3595

www.IntegrityMedia.com

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

You May Also Be Interested In

• Vaxxinity, Inc (VAXX) to Voluntarily Delist
• Nutriband (NTRB) Announces 2.1M Share Offering at $4/sh
• Esquire Financial (ESQ) Files $100M Mixed Shelf